- Home
- EZGO vs ZVSA Comparison
EZGO vs ZVSA Comparison
Compare EZGO & ZVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- ZVSA
- Stock Information
- Founded
- EZGO 2014
- ZVSA 2014
- Country
- EZGO China
- ZVSA United States
- Employees
- EZGO N/A
- ZVSA N/A
- Industry
- EZGO Motor Vehicles
- ZVSA Biotechnology: Pharmaceutical Preparations
- Sector
- EZGO Consumer Discretionary
- ZVSA Health Care
- Exchange
- EZGO Nasdaq
- ZVSA Nasdaq
- Market Cap
- EZGO 1.6M
- ZVSA 1.5M
- IPO Year
- EZGO 2021
- ZVSA N/A
- Fundamental
- Price
- EZGO $0.59
- ZVSA $1.42
- Analyst Decision
- EZGO
- ZVSA Strong Buy
- Analyst Count
- EZGO 0
- ZVSA 1
- Target Price
- EZGO N/A
- ZVSA $240.00
- AVG Volume (30 Days)
- EZGO 1.6M
- ZVSA 2.2M
- Earning Date
- EZGO 01-28-2025
- ZVSA 11-14-2024
- Dividend Yield
- EZGO N/A
- ZVSA N/A
- EPS Growth
- EZGO N/A
- ZVSA N/A
- EPS
- EZGO N/A
- ZVSA N/A
- Revenue
- EZGO $21,134,425.00
- ZVSA N/A
- Revenue This Year
- EZGO N/A
- ZVSA N/A
- Revenue Next Year
- EZGO N/A
- ZVSA N/A
- P/E Ratio
- EZGO N/A
- ZVSA N/A
- Revenue Growth
- EZGO 14.03
- ZVSA N/A
- 52 Week Low
- EZGO $0.51
- ZVSA $0.98
- 52 Week High
- EZGO $4.56
- ZVSA $25.00
- Technical
- Relative Strength Index (RSI)
- EZGO 37.36
- ZVSA 57.25
- Support Level
- EZGO $0.53
- ZVSA $1.31
- Resistance Level
- EZGO $0.64
- ZVSA $1.95
- Average True Range (ATR)
- EZGO 0.12
- ZVSA 0.19
- MACD
- EZGO -0.00
- ZVSA 0.04
- Stochastic Oscillator
- EZGO 12.97
- ZVSA 44.21
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.